Intravitreal implants comprising microspheres which encapsulate a tyrosine kinase inhibitor and a biodegradable polymer

Details for Australian Patent Application No. 2005244780 (hide)

Owner Allergan, Inc.

Inventors Sarrazin, Christian; Boix, Michele; Rossi, Elisabeth; Hughes, Patrick M.

Agent Davies Collison Cave

Pub. Number AU-B-2005244780

PCT Pub. Number WO2005/112884

Priority 10/837,361 30.04.04 US

Filing date 27 April 2005

Wipo publication date 1 December 2005

Acceptance publication date 25 March 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/00 (2006.01)

A61K 31/404 (2006.01)

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/112884 Priority application(s): WO2005/112884

25 March 2010 Application Accepted

  Published as AU-B-2005244780

22 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244782-Devices, systems, and methods for reshaping a heart valve annulus

2005244774-Selective filtration of cigarette smoke using chitosan derivatives